Novorapid Innolet (Insulin Aspart)

Insulin aspart, the active ingredient in Novorapid Innolet, is a rapid-acting insulin analog presented as a solution for subcutaneous injection use. It treats high blood glucose in people with diabetes mellitus. GNH USA supplies Novorapid Innolet as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals worldwide.

GNH USA supplies Novorapid Innolet as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Novorapid Innolet is a rapid‑acting insulin analog that lowers blood glucose by acting on the insulin pathway.

- Diabetes mellitus type 1: Improves post‑prandial glucose control. - Diabetes mellitus type 2: Enhances glycemic control especially when used with basal insulin. - Gestational diabetes: Assists in managing post‑meal blood sugar levels. - Pre‑bypass ​      t